Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.

Frontiers in Immunology（2024）

引用 0|浏览5

暂无评分

摘要

[This corrects the article DOI: 10.3389/fimmu.2023.1280580.].

查看译文

关键词

B cell aplasia,late B-cell recovery,pre-infusion tumor burden,CD19 CART-cells,relapsed/refractory acute lymphoblastic leukemia,tisagenlecleucel

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要